Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitomi Hoshi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Omega|August 15, 2022
Formation of a Pt-MgO Solid Solution: Analysis by X-ray Absorption Fine Structure SpectroscopyKazu Okumura, Hitomi Hoshi, Hikaru Iiyoshi, et al.
Biomedical Reports|December 19, 2017
Tolvaptan is effective in treating patients with refractory ascites due to cirrhosisToshiyuki Tahara, Kiyoto Mori, Mari Mochizuki, et al.
Cureus|July 29, 2024
Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic GastritisHiroshi Kishikawa, Kenji Nakamura, Sakiko Takarabe, et al.
Scientific Reports|March 11, 2022
Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritisHiroshi Kishikawa, Kenji Nakamura, Keisuke Ojiro, et al.
Plos One|April 13, 2021
Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosisHitomi Hoshi, Po-Sung Chu, Aya Yoshida, et al.
Immunological Medicine|July 6, 2026
Early steroid initiation may improve outcomes in immune checkpoint inhibitor-related cholangitis: a multicenter cohort studyMayuko Kondo, Keisuke Ojiro, Makoto Ueno, et al.
Hepatology Communications|July 7, 2020
CLIF-C Organ Failure Score and Liver Volume Predict Prognosis in Steroid-Treated Severe Acute Autoimmune HepatitisAkihiko Ikura, Po-Sung Chu, Nobuhiro Nakamoto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2021
Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune HepatitisFumie Noguchi, Po-Sung Chu, Aya Yoshida, et al.
Cancer Medicine|January 17, 2026
Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort StudyNobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga, et al.
Scientific Reports|May 13, 2024
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinomaRyosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Omega|August 15, 2022
Formation of a Pt-MgO Solid Solution: Analysis by X-ray Absorption Fine Structure SpectroscopyKazu Okumura, Hitomi Hoshi, Hikaru Iiyoshi, et al.
Biomedical Reports|December 19, 2017
Tolvaptan is effective in treating patients with refractory ascites due to cirrhosisToshiyuki Tahara, Kiyoto Mori, Mari Mochizuki, et al.
Cureus|July 29, 2024
Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic GastritisHiroshi Kishikawa, Kenji Nakamura, Sakiko Takarabe, et al.
Scientific Reports|March 11, 2022
Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritisHiroshi Kishikawa, Kenji Nakamura, Keisuke Ojiro, et al.
Plos One|April 13, 2021
Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosisHitomi Hoshi, Po-Sung Chu, Aya Yoshida, et al.
Immunological Medicine|July 6, 2026
Early steroid initiation may improve outcomes in immune checkpoint inhibitor-related cholangitis: a multicenter cohort studyMayuko Kondo, Keisuke Ojiro, Makoto Ueno, et al.
Hepatology Communications|July 7, 2020
CLIF-C Organ Failure Score and Liver Volume Predict Prognosis in Steroid-Treated Severe Acute Autoimmune HepatitisAkihiko Ikura, Po-Sung Chu, Nobuhiro Nakamoto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2021
Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune HepatitisFumie Noguchi, Po-Sung Chu, Aya Yoshida, et al.
Cancer Medicine|January 17, 2026
Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort StudyNobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga, et al.
Scientific Reports|May 13, 2024
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinomaRyosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, et al.
Pageof 2